Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03277924
Title	Trial of Sunitinib Plus Nivolumab After Standard Treatment in Advanced Soft Tissue and Bone Sarcomas (ImmunoSarc)
Acronym	ImmunoSarc
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Grupo Espanol de Investigacion en Sarcomas
Indications	extraskeletal myxoid chondrosarcoma malignant fibrous histiocytoma osteosarcoma malignant epithelioid hemangioendothelioma leiomyosarcoma alveolar soft part sarcoma solitary fibrous tumor/hemangiopericytoma chondrosarcoma angiosarcoma clear cell sarcoma
Therapies	Nivolumab + Sunitinib
Age Groups:	adult \| child \| senior
Covered Countries	ITA \| GBR \| ESP